Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting proprotein convertase subtilisin/kexin type 9 in mice and monkeys.

× No keyword cloud information.

15 in total

Review 1. Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council.

Authors: Peggy Robinet; Dianna M Milewicz; Lisa A Cassis; Nicholas J Leeper; Hong S Lu; Jonathan D Smith
Journal: Arterioscler Thromb Vasc Biol Date: 2018-01-04 Impact factor: 8.311

Review 2. Key aspects of PCSK9 inhibition beyond LDL lowering.

Authors: Stéphane Ramin-Mangata; Valentin Blanchard; Gilles Lambert
Journal: Curr Opin Lipidol Date: 2018-12 Impact factor: 4.776

3. In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.

Authors: Alexandra C Chadwick; Xiao Wang; Kiran Musunuru
Journal: Arterioscler Thromb Vasc Biol Date: 2017-07-27 Impact factor: 8.311

4. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.

Authors: Marta Roche-Molina; David Sanz-Rosa; Francisco M Cruz; Jaime García-Prieto; Sergio López; Rocío Abia; Francisco J G Muriana; Valentín Fuster; Borja Ibáñez; Juan A Bernal
Journal: Arterioscler Thromb Vasc Biol Date: 2014-10-23 Impact factor: 8.311

Review 5. Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases.

Authors: Arthur P Arnold; Lisa A Cassis; Mansoureh Eghbali; Karen Reue; Kathryn Sandberg
Journal: Arterioscler Thromb Vasc Biol Date: 2017-03-09 Impact factor: 8.311

6. Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.

Authors: Hong Lu; Deborah A Howatt; Anju Balakrishnan; Mark J Graham; Adam E Mullick; Alan Daugherty
Journal: Arterioscler Thromb Vasc Biol Date: 2016-07-28 Impact factor: 8.311

Review 7. Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association.

Authors: Alan Daugherty; Alan R Tall; Mat J A P Daemen; Erling Falk; Edward A Fisher; Guillermo García-Cardeña; Aldons J Lusis; A Phillip Owens; Michael E Rosenfeld; Renu Virmani
Journal: Arterioscler Thromb Vasc Biol Date: 2017-07-20 Impact factor: 8.311

Review 8. PCSK9: a key modulator of cardiovascular health.

Authors: Nabil G Seidah; Zuhier Awan; Michel Chrétien; Majambu Mbikay
Journal: Circ Res Date: 2014-03-14 Impact factor: 17.367

9. A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification.

Authors: Claudia Goettsch; Joshua D Hutcheson; Sumihiko Hagita; Maximillian A Rogers; Michael D Creager; Tan Pham; Jung Choi; Andrew K Mlynarchik; Brett Pieper; Mads Kjolby; Masanori Aikawa; Elena Aikawa
Journal: Atherosclerosis Date: 2016-06-09 Impact factor: 5.162

10. Accelerated atherosclerosis development in C57Bl6 mice by overexpressing AAV-mediated PCSK9 and partial carotid ligation.

Authors: Sandeep Kumar; Dong-Won Kang; Amir Rezvan; Hanjoong Jo
Journal: Lab Invest Date: 2017-05-15 Impact factor: 5.662

1 in total

1. Liraglutide blocks the proliferation, migration and phenotypic switching of Homocysteine (Hcy)-induced vascular smooth muscle cells (VSMCs) by suppressing proprotein convertase subtilisin kexin9 (PCSK9)/ low-density lipoprotein receptor (LDLR).

Authors: Jingquan Ji; Ming Feng; Xiaohong Niu; Xinyu Zhang; Yilei Wang
Journal: Bioengineered Date: 2021-12 Impact factor: 3.269

1 in total